Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy)

Martin H Ruwald, Abeer Abu-Zeitone, Christian Jons, Anne-Christine Ruwald, Scott McNitt, Valentina Kutyifa, Wojciech Zareba, Arthur J Moss

    33 Citations (Scopus)

    Abstract

    The goal of this study was to evaluate the effects of carvedilol and metoprolol on the endpoint of inappropriate implantable cardioverter-defibrillator therapy in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy) study.
    Original languageEnglish
    JournalJournal of the American College of Cardiology
    Volume62
    Issue number15
    Pages (from-to)1343-50
    Number of pages8
    ISSN0735-1097
    DOIs
    Publication statusPublished - 8 Oct 2013

    Keywords

    • Adrenergic beta-1 Receptor Antagonists
    • Adrenergic beta-Antagonists
    • Aged
    • Atrial Fibrillation
    • Carbazoles
    • Cardiac Resynchronization Therapy
    • Combined Modality Therapy
    • Defibrillators, Implantable
    • Female
    • Heart Failure
    • Humans
    • Male
    • Metoprolol
    • Multivariate Analysis
    • Propanolamines
    • Regression Analysis

    Fingerprint

    Dive into the research topics of 'Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy)'. Together they form a unique fingerprint.

    Cite this